About STAAR Surgical Company
Ticker
info
STAA
Trading on
info
NASDAQ
ISIN
info
US8523123052
Industry
info
Medical Instruments & Supplies
Sector
info
Healthcare
CEO
info
Stephen C. Farrell CFA
Headquarters
info
25510 Commercentre Drive, Lake Forest, CA, United States, 92630
Employees
info
1,157
Website
info
staar.com
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) and laser-based procedures, such as LASIK to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It serves its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
Metrics
BasicAdvanced
Market cap
info
$861M
P/E ratio
info
-
EPS
info
-$1.44
Dividend Yield
info
0.00%
Beta
info
0.61
Forward P/E ratio
info
625
EBIDTA
info
$-36.8M
Ex dividend date
info
-
Price & volume
Market cap
info
$861M
Average daily volume
info
0.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
625
PEG ratio
info
-4.89
Trailing P/E
info
0
Price to sales
info
3.08
Price to book
info
2.46
Earnings
EPS
info
-$1.44
EPS estimate (current quarter)
info
-$0.60
EPS estimate (next quarter)
info
-$0.60
EBITDA
info
$-36.8M
Revenues (TTM)
info
$279M
Revenues per share (TTM)
info
$5.67
Technicals
Beta
info
0.61
52-week High
info
$46.79
52-week Low
info
$13.50
50-day moving average
info
$17.85
200-day moving average
info
$22.32
Short ratio
info
8.13
Short %
info
29.52%
Management effectiveness
ROE (TTM)
info
-19.14%
ROA (TTM)
info
-5.90%
Profit margin
info
-25.46%
Gross profit margin
info
$207M
Operating margin
info
-81.43%
Growth
Quarterly earnings growth (YoY)
info
101.80%
Quarterly revenue growth (YoY)
info
-44.90%
Share stats
Outstanding Shares
info
49.5M
Float
info
30.2M
Insiders %
info
0.64%
Institutions %
info
109.43%
Analyst Insights & forecasts
info

22% Buy

71% Hold

7% Sell

Based on information from 14 analysts.

Average price target

info
$19.10
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
$0.15
$0.24
-37.50%
Q2 • 24Missed
$0.20
$0.18
11.11%
Q3 • 24Beat
-$0.69
-$0.03
-2,200.00%
Q4 • 24Missed
-$1.10
-$0.58
-89.66%
Q1 • 25Missed
-
-$0.56
100.00%
Q2 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$49M
$-34.2M
-69.92%
Q4 • 24
$42.6M
$-54.2M
-127.29%
Q1 • 25
-12.99%
58.38%
82.04%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$510M
$112M
22.02%
Q4 • 24
$457M
$107M
23.48%
Q1 • 25
-10.24%
-4.28%
6.64%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$0.6M
$-19.5M
$-0.1M
$-5.1M
Q4 • 24
$-5.7M
$35.4M
$-0.9M
$-7.2M
Q1 • 25
-993.15%
-281.33%
761.82%
41.69%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a STAAR Surgical Company share?
Collapse

STAAR Surgical Company shares are currently traded for undefined per share.

How many shares does STAAR Surgical Company have?
Collapse

STAAR Surgical Company currently has 49.5M shares.

Does STAAR Surgical Company pay dividends?
Collapse

No, STAAR Surgical Company doesn't pay dividends.

What is STAAR Surgical Company 52 week high?
Collapse

STAAR Surgical Company 52 week high is $46.79.

What is STAAR Surgical Company 52 week low?
Collapse

STAAR Surgical Company 52 week low is $13.50.

What is the 200-day moving average of STAAR Surgical Company?
Collapse

STAAR Surgical Company 200-day moving average is $22.32.

Who is STAAR Surgical Company CEO?
Collapse

The CEO of STAAR Surgical Company is Stephen C. Farrell CFA.

How many employees STAAR Surgical Company has?
Collapse

STAAR Surgical Company has 1,157 employees.

What is the market cap of STAAR Surgical Company?
Collapse

The market cap of STAAR Surgical Company is $861M.

What is the P/E of STAAR Surgical Company?
Collapse

The current P/E of STAAR Surgical Company is null.

What is the EPS of STAAR Surgical Company?
Collapse

The EPS of STAAR Surgical Company is -$1.44.

What is the PEG Ratio of STAAR Surgical Company?
Collapse

The PEG Ratio of STAAR Surgical Company is -4.89.

What do analysts say about STAAR Surgical Company?
Collapse

According to the analysts STAAR Surgical Company is considered a hold.